HOW TO RECORD TEST RESULTS
5
© 2022 Abbott. All rights reserved. All trademarks referenced are trademarks of either the Abbott group of companies or their respective
owners. Any photos displayed are for illustrative purposes only. COL-06949-03 01/22
The BinaxNOW™ COVID-19 Antigen Self Test has not been FDA cleared or approved. It has been authorized by the FDA under an
emergency use authorization. It has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses
or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of
emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug
and Cosmetic Act, 21 U.S.C. § 360bbb 3(b)(1), unless the declaration is terminated or authorization is revoked sooner. For serial testing,
the BinaxNOW COVID-19 Antigen Self Test should be performed twice over 3 days, at least 24 hours (and no more than 48 hours) apart.
For symptomatic use, a single test can be used.
After returning to the
home screen, you will
now see the Latest Test
Result reported in the
profile for this person.
Important:
If applicable, retest
using the BinaxNOW™
COVID-19 Antigen Self
Test within 3 days of the
first test performed. Then,
self-report the test results.
Allow at least 24 hours
(and no more than
48 hours) between the
first and second tests.